Spacer
Spacer Home  |  Contact Us Spacer
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
spacer
Banner for Physician section
spacer
spacer

Educational Resources

Bardella, M.,et. al. (2007).  “Celiac Disease:  A Histologic Follow-Up Study.”  Histopathology 50: 465-471.

Bethune, M. T., P. Strop, et al. (2006). “Heterologous expression, purification, refolding, and structural-functional characterization of EP-B2, a self-activating barley cysteine endoprotease.” Chem Biol 13(6): 637-47.

Bianchi, M., Bardella, M. (2008).  “Bone in Celiac Disease.”  Osteoporosis Int. 2008

Cerf-Bensussan, N., T. Matysiak-Budnik, et al. (2007). “Oral proteases: a new approach to managing coeliac disease.” Gut 56(2): 157-60.

Cranney, A., et. al. (2007).  “The Canadian Celiac Health Survey.”  Dig Dis Sci 52: 1087-1095.

Green, P.H. et. al. (2008).  “Economic Benefits of Increased Diagnosis of Celiac Disease in a National Managed Care Population in the United States.”  Journal of Insurance Medicine 40: 218-228.

Green, P. H. (2007). “Where are all those patients with Celiac disease?” Am J Gastroenterol 102(7): 1461-3.

Green, P. H. and C. Cellier (2007). “Celiac disease.” N Engl J Med 357(17): 1731-43.

Hausch, F., L. Shan, et al. (2002). “Intestinal digestive resistance of immunodominant gliadin peptides.” Am J Physiol Gastrointest Liver Physiol 283(4): G996-G1003.

Hopman, E. (2008).  “Tef in the Diet of Celiac Patients in the Netherlands.”  Scandinavian Journal of Gastroenterology 43: 277-282.

Jabri, B. and L. M. Sollid (2006). “Mechanisms of disease: immunopathogenesis of celiac disease.” Nat Clin Pract Gastroenterol Hepatol 3(9): 516-25.

Kagnoff, M. F. (2007). “Celiac disease: pathogenesis of a model immunogenetic disease.” J Clin Invest 117(1): 41-9.

Kim, C. Y., H. Quarsten, et al. (2004). “Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease.” Proc Natl Acad Sci U S A 101(12): 4175-9.

Lee, S. K., W. Lo, et al. (2003). “Duodenal histology in patients with celiac disease after treatment with a gluten-free diet.” Gastrointestinal Endoscopy 57(2): 187-191.

Marsh, M. N. and P. T. Crowe (1995). “5 Morphology of the mucosal lesion in gluten sensitivity.” Bailliere’s Clinical Gastroenterology 9(2): 273-293.

Midhagen, G., et al (2003). “High Rate of Gastrointestinal Symptoms in Celiac Patients Living on a Gluten-Free Diet: Controlled Study.”  The American Journal of Gastroenterology 98(9): 2-23-2026.

National Guideline Clearinghouse (NCG) Guideline Synthesis: Diagnosis and Management of Celiac Disease, April 2010. 

Peters, U., J. Askling, et al. (2003). “Causes of death in patients with celiac disease in a population-based Swedish cohort.” Arch Intern Med 163(13): 1566-72.

Rostom, A., C. Dube, et al. (2005). “The diagnostic accuracy of serologic tests for celiac disease: a systematic review.” Gastroenterology 128(4 Suppl 1): S38-46.

Rostom, A., J. A. Murray, et al. (2006). “American Gastroenterological Association (AGA) Institute Technical Review on the Diagnosis and Management of Celiac Disease.” Gastroenterology 131(6): 1981-2002.

Rubio-Tapia, A., Murray, J. A., et al. (2010). “Mucosal Recovery and Mortality in Adults with Celiac Disease After Treatment With a Gluten-Free Diet.”  Am J Gastroenterology 105 (6): 1412-1420.

Rubio-Tapia, A., Murray, J., et. al. (2009).  “Increased Prevalence and Mortality in Undiagnosed Celiac Disease.”  Gastroenterology 137: 88-93. 

Schuppan, D., et. al. (2009).  “Celiac Disease: From Pathogenesis to Novel Therapies, Reviews in Basic and Clinical Gastroenterology.”  Gastroenterology 137: 1912-1933. 

Shan, L., O. Molberg, et al. (2002). “Structural basis for gluten intolerance in celiac sprue.” Science 297(5590): 2275-9.

Shan, L., S. W. Qiao, et al. (2005). “Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue.” J Proteome Res 4(5): 1732-41.

Shiner (1973 ). “Ultrastructural changes suggestive of immune reactions in the jejunal mucosa of coeliac children following gluten challenge.” Gut 14 1-12.

Sollid, L. M. and C. Khosla (2005). “Future therapeutic options for celiac disease.” Nat Clin Pract Gastroenterol Hepatol 2(3): 140-7.

Van Heel, D. A. and J. West (2006). “Recent advances in coeliac disease.” Gut 55(7): 1037-46.


Back To Top
 

www.clinicaltrials.gov >>   

spacer
spacer

Location

Alvine Pharmaceuticals, Inc.
Headquarters
75 Shoreway Rd., Suite B
San Carlos, CA 94070
view all contact info >>

Business Inquiries

Kirk Essenmacher, M.D., M.B.A.
T: (650) 596-2434
E: email BD >>

Clinical Inquiries

E: email info@alvinepharma.com >>

spacer
spacer